Hollsteen
← NXP

D&A

Flow – sum over the period · $M

QuartersFiscal years

$MD&A · Q1 2016: missing – No verified SEC value extracted, although the company reports this metric in other periods.D&A · Q2 2016: missing – No verified SEC value extracted, although the company reports this metric in other periods.D&A · Q3 2016: missing – No verified SEC value extracted, although the company reports this metric in other periods.D&A · Q4 2016: missing – No verified SEC value extracted, although the company reports this metric in other periods.D&A · Q1 2017: missing – No verified SEC value extracted, although the company reports this metric in other periods.D&A · Q2 2017: missing – No verified SEC value extracted, although the company reports this metric in other periods.D&A · Q3 2017: missing – No verified SEC value extracted, although the company reports this metric in other periods.D&A · Q4 2017: missing – No verified SEC value extracted, although the company reports this metric in other periods.D&A · Q1 2018: missing – No verified SEC value extracted, although the company reports this metric in other periods.D&A · Q2 2018: missing – No verified SEC value extracted, although the company reports this metric in other periods.D&A · Q3 2018: $497M · 10-Q 0001413447-19-000035 filed Oct 29, 2019D&A · Q4 2018: $503M · derived · 10-K 0001413447-20-000009 filed Feb 27, 2020D&A · Q1 2019: $502M · 10-Q 0001413447-20-000026 filed Apr 28, 2020D&A · Q2 2019: $506M · 10-Q 0001413447-20-000056 filed Jul 28, 2020D&A · Q3 2019: $517M · 10-Q 0001413447-19-000035 filed Oct 29, 2019D&A · Q4 2019: $522M · derived · 10-K 0001413447-21-000011 filed Feb 25, 2021D&A · Q1 2020: $540M · 10-Q 0001413447-20-000026 filed Apr 28, 2020D&A · Q2 2020: $543M · 10-Q 0001413447-20-000056 filed Jul 28, 2020D&A · Q3 2020: $589M · 10-Q 0001413447-20-000084 filed Oct 27, 2020D&A · Q4 2020: $316M · derived · 10-K 0001413447-22-000008 filed Feb 24, 2022D&A · Q1 2021: $341M · 10-Q 0001413447-21-000032 filed Apr 27, 2021D&A · Q2 2021: $305M · 10-Q 0001413447-21-000062 filed Aug 3, 2021D&A · Q3 2021: $306M · 10-Q 0001413447-21-000094 filed Nov 2, 2021D&A · Q4 2021: $310M · derived · 10-K 0001413447-23-000006 filed Mar 1, 2023D&A · Q1 2022: $310M · 10-Q 0001413447-22-000014 filed May 3, 2022D&A · Q2 2022: $317M · 10-Q 0001413447-22-000049 filed Jul 26, 2022D&A · Q3 2022: $321M · 10-Q 0001413447-22-000067 filed Nov 1, 2022D&A · Q4 2022: $302M · derived · 10-K 0001413447-24-000013 filed Feb 22, 2024D&A · Q1 2023: $283M · 10-Q 0001413447-23-000020 filed May 2, 2023D&A · Q2 2023: $281M · 10-Q 0001413447-23-000059 filed Jul 25, 2023D&A · Q3 2023: $273M · 10-Q 0001413447-23-000107 filed Nov 7, 2023D&A · Q4 2023: $269M · derived · 10-K 0001413447-25-000019 filed Feb 20, 2025D&A · Q1 2024: $235M · 10-Q 0001413447-24-000038 filed Apr 30, 2024D&A · Q2 2024: $213M · 10-Q 0001413447-24-000072 filed Jul 23, 2024D&A · Q3 2024: $218M · 10-Q 0001413447-24-000089 filed Nov 5, 2024D&A · Q4 2024: $259M · derived · 10-K 0001413447-26-000008 filed Feb 19, 2026D&A · Q1 2025: $209M · 10-Q 0001413447-25-000031 filed Apr 29, 2025D&A · Q2 2025: $207M · 10-Q 0001413447-25-000106 filed Jul 24, 2025D&A · Q3 2025: $201M · 10-Q 0001413447-25-000120 filed Oct 28, 2025D&A · Q4 2025: $215M · derived · 10-K 0001413447-26-000008 filed Feb 19, 2026D&A · Q1 2026: $179M · 10-Q 0001413447-26-000034 filed Apr 28, 2026missing305179497589Q1 2016Q1 2026Q2 2021
$MD&A · Q2 2020: $543M · 10-Q 0001413447-20-000056 filed Jul 28, 2020D&A · Q3 2020: $589M · 10-Q 0001413447-20-000084 filed Oct 27, 2020D&A · Q4 2020: $316M · derived · 10-K 0001413447-22-000008 filed Feb 24, 2022D&A · Q1 2021: $341M · 10-Q 0001413447-21-000032 filed Apr 27, 2021D&A · Q2 2021: $305M · 10-Q 0001413447-21-000062 filed Aug 3, 2021D&A · Q3 2021: $306M · 10-Q 0001413447-21-000094 filed Nov 2, 2021D&A · Q4 2021: $310M · derived · 10-K 0001413447-23-000006 filed Mar 1, 2023D&A · Q1 2022: $310M · 10-Q 0001413447-22-000014 filed May 3, 2022305310543589Q2 2020Q1 2022Q2 2021
Q2 2021
305$M
All values (31)
PeriodValue ($M)Status
Q1 2026179reported
Q4 2025215derived
Q3 2025201reported
Q2 2025207reported
Q1 2025209reported
Q4 2024259derived
Q3 2024218reported
Q2 2024213reported
Q1 2024235reported
Q4 2023269derived
Q3 2023273reported
Q2 2023281reported
Q1 2023283reported
Q4 2022302derived
Q3 2022321reported
Q2 2022317reported
Q1 2022310reported
Q4 2021310derived
Q3 2021306reported
Q2 2021305reported
Q1 2021341reported
Q4 2020316derived
Q3 2020589reported
Q2 2020543reported
Q1 2020540reported
Q4 2019522derived
Q3 2019517reported
Q2 2019506reported
Q1 2019502reported
Q4 2018503derived
Q3 2018497reported
Q1 2016 – Q2 2018–missing (10 periods): No verified SEC value extracted, although the company reports this metric in other periods.

Show reported periods only · CSV with all sources · Technical ID: dna

More metrics for NXP

Income statement

Per share

Balance sheet

Cash flow

Debt and interest

Revenue by segment/product/region

Sources & calculation
Value
$305M
Period
Q2 2021, ended Jul 4, 2021 · quarterly value (3 months, not cumulative)
Source
10-Q, filed Aug 3, 2021 · 0001413447-21-000062
Location
us-gaap:DepreciationDepletionAndAmortization
Confidence
1. – directly from an XBRL fact in the filing (or calculated exactly from it)

Versions

v1$305MAug 3, 202110-Q 0001413447-21-000062reported · confidence 1. · current